A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Public ClinicalTrials.gov record NCT00429091. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose-Ranging Study of the Safety and Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Dose-Ranging Study of the Efficacy of ABT-894 in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
Study identification
- NCT ID
- NCT00429091
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 243 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2007 (Type not available)
- Primary completion
- Aug 2007 (Actual)
- Completion
- Not listed
- Last update posted
- Nov 2, 2010
Started 2007
United States locations
- U.S. sites
- 22
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 5965 | San Francisco | California | 94143-0984 | — |
| Site Reference ID/Investigator# 5955 | Wildomar | California | 92595 | — |
| Site Reference ID/Investigator# 5974 | Orlando | Florida | 32806 | — |
| Site Reference ID/Investigator# 5956 | West Palm Beach | Florida | 33407 | — |
| Site Reference ID/Investigator# 5973 | Libertyville | Illinois | 60048 | — |
| Site Reference ID/Investigator# 5968 | Overland Park | Kansas | 66212 | — |
| Site Reference ID/Investigator# 5952 | Rockville | Maryland | 20852 | — |
| Site Reference ID/Investigator# 5962 | Boston | Massachusetts | 02114 | — |
| Site Reference ID/Investigator# 5954 | Okemos | Michigan | 48864 | — |
| Site Reference ID/Investigator# 5970 | Troy | Michigan | 48085 | — |
| Site Reference ID/Investigator# 5960 | Clementon | New Jersey | 08021 | — |
| Site Reference ID/Investigator# 5963 | Charlotte | North Carolina | 28211 | — |
| Site Reference ID/Investigator# 5975 | Eugene | Oregon | 97401 | — |
| Site Reference ID/Investigator# 5971 | Philadelphia | Pennsylvania | 19149 | — |
| Site Reference ID/Investigator# 5957 | Charleston | South Carolina | 29407 | — |
| Site Reference ID/Investigator# 5972 | Austin | Texas | 78756 | — |
| Site Reference ID/Investigator# 5959 | Bellaire | Texas | 77401 | — |
| Site Reference ID/Investigator# 5969 | San Antonio | Texas | 78258 | — |
| Site Reference ID/Investigator# 5951 | Salt Lake City | Utah | 84107 | — |
| Site Reference ID/Investigator# 5964 | Burlington | Vermont | 05401 | — |
| Site Reference ID/Investigator# 5953 | Virginia Beach | Virginia | 23452 | — |
| Site Reference ID/Investigator# 5958 | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00429091, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 2, 2010 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00429091 live on ClinicalTrials.gov.